To establish a reliable evidence base in the field of ceramic implantology, a retrospective multicenter data analysis is planned. In three participating centers, approximately 120 ceramic implants each will be analyzed, all of which were placed between 2015 and 2020. Only immediate implants will be included in the data collection.

IC IMPLANTS

The primary endpoints of the study are implant survival, implant success, and the evaluation of marginal bone levels based on existing standardized radiographs from the clinical follow-up routines of the participating centers. As a secondary endpoint, a cross-sectional analysis of peri-implant parameters is planned. These parameters were recorded during the centers’ follow-up routines and aim to provide insights into the peri-implant soft and hard tissue situation after at least five years in situ.

As part of this cross-sectional assessment, clinical parameters relevant to the diagnosis of peri-implant diseases will be examined, including probing depths, bleeding on probing (BOP), and the extent of radiographically detectable bone loss. Non-inflammatory buccal recessions will also be recorded.

The study aims to address two essential pillars of evidence generation for ceramic implants: firstly, the longitudinal evaluation of long-term implantological outcomes, and secondly, the collection of valid cross-sectional data on the prevalence of peri-implant inflammation associated with ceramic implants.

Data collection is expected to begin promptly following the required ethics approval. The planned study is designed to answer key, previously unresolved questions regarding the success and peri-implant health of immediately loaded ceramic implants.